Millennium Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Millennium Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-272,954	Closed	-$4.63M	–	4544
2014 Q4	$4.63M	Sell	272,954 -3,349,443	-92%	-$47.1M	0.01%	1441
2014 Q3	$43.2M	Sell	3,622,397 -1,246,160	-26%	-$8.51M	0.11%	196
2014 Q2	$27.5M	Buy	4,868,557 +2,492,944	+105%	+$11.5M	0.08%	342
2014 Q1	$8.72M	Sell	2,375,613 -263,142	-10%	-$1M	0.03%	888
2013 Q4	$8.87M	Buy	2,638,755 +2,220,235	+530%	+$9.17M	0.03%	792
2013 Q3	$1.77M	Buy	418,520 +113,589	+37%	+$538K	0.01%	1762
2013 Q2	$1.4M	Buy	+304,931	New	+$1.05M	﹤0.01%	1789

Millennium Management's AVNR Position: Q1 2015 in Review

Millennium Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 272,954 shares — an estimated $4.63M sold.

Millennium Management first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $43.2M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Millennium Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Millennium Management sold 272,954 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $4.63M.
Millennium Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
Millennium Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $43.2M in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Millennium Management's 13F filing for Q1 2015, filed 15 May 2015.